Agilon Health (AGL) Invested Capital (2020 - 2026)

Agilon Health (AGL) has 7 years of Invested Capital data on file, last reported at $277.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 56.04% year-over-year to $277.7 million; the trailing twelve-month figure through Mar 2026 stood at $277.7 million (down 56.04% YoY), and the FY2025 full-year result was $258.3 million, down 51.82% from the prior year.
• Invested Capital for Q1 2026 stood at $277.7 million, up from $258.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $1.1 billion in Q1 2022 and bottomed at $258.3 million in Q4 2025.
• The 5-year median for Invested Capital is $699.5 million (2023), against an average of $735.6 million.
• The widest annual swing landed in 2022, when Invested Capital jumped 474.35%; it then tumbled 56.04% in 2026.
• A 5-year view of Invested Capital shows it stood at $1.0 billion in 2022, then sank by 33.1% to $699.5 million in 2023, then decreased by 23.35% to $536.2 million in 2024, then slumped by 51.82% to $258.3 million in 2025, then grew by 7.51% to $277.7 million in 2026.
• The last three Invested Capital figures came in at $277.7 million (Q1 2026), $258.3 million (Q4 2025), and $341.1 million (Q3 2025), per Business Quant data.

Peer Comparison